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1684-1182/Copyright ª 2015, TaiwanBackground/Purpose: The aim of this study is to characterize antibiotic-nonsusceptible Salmo-
nella isolates in Taiwan.
Methods: A total of 76 Salmonella isolates showing lower susceptibility to cephalosporins or
quinolones were identified from 1416 clinical isolates from 1999 to 2008. Minimal inhibitory
concentrations for selected antimicrobial agents were tested by the agar dilution method.
Antibiotic resistance-related genes were determined by polymerase chain reaction (PCR) com-
bined with sequencing. Southern blotting, conjugation tests, and transformation tests were
used to characterize plasmid-mediated quinolone resistance (PMQR) determinants.
Results: The observed nonsusceptible phenotypes of 76 isolates were against cefoxitin (57.9%),
cefotaxime (43.4%), ceftazidime (40.8%), ceftriaxone (42.1%), cefepime (5.3%), ciprofloxacin
(80.3%), and levofloxacin (81.6%). Among 44 cephalosporin-resistant isolates, TEM-1, CMY-2,
CMY-14, CTX-M-3-like and CTX-M-15-like determinants were present in 31 (70.5%), 32
(72.7%), 1 (2.3%), 1 (2.3%), and 1 (2.3%) of isolates, respectively. PCR screening for PMQR genes
of 62 quinolone-nonsusceptible isolates revealed the presence of qnrS, qnrD, aac(60)-Ib-cr, andt of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung
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dx.doi.org/10.1016/j.jmii.2015.03.00oqxAB in 3 (4.8%), 2 (3.2%), 1 (1.6%), and 10 (16.1%) isolates, respectively. Among 36 isolates
showing high resistance to quinolones, S83F/D87N and S83F/D87G amino acid substitutions of
GyrA were found in 29 (80.6%) and 6 (16.7%) isolates, respectively. Moreover, among quinolone
highly resistant isolates, eight (22.2%) of isolates showed over-expression of the PAbN-sensitive
efflux pump. Transformants and transconjugants harboring qnrD- or oqxAB-plasmids showed
decreased susceptibility to quinolones.
Conclusion: GyrA mutations are the major mechanisms associated with quinolone-resistant
Salmonella isolates in Taiwan. Overproduction of efflux pump genes and the presence of qnr
and oqxAB play additional roles in reduced susceptibility to quinolones.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Salmonellosis is a major cause of food-borne gastroenteritis
in humans worldwide.1 Currently, among the high diversity
of Salmonella enterica serovars, S. enterica serovar
Typhimurium, and S. enterica serovar Enteritidis are the
most common serovars isolated from humans in East
Asia.2,3 Multidrug resistance to antimicrobial agents is a
growing concern with Salmonella as it limits treatment
options for invasive disease and could lead to the transfer
of resistant determinants to other pathogenic organisms. In
the last few years, the prevalence of multidrug-resistant
(MDR) Salmonella isolates has increased, such as Salmo-
nella enterica serotype 4,[5],12:i:-.2,4 The most important
concern regarding the increase of MDR Salmonella isolates
is the increase in resistance to expanded-spectrum ceph-
alosporins (ESCs) and the decrease in susceptibility to
quinolones, which are commonly used to treat
salmonellosis.2,5
Unlike most of the clinically significant Enter-
obacteriaceae, chromosomal mutations play a minor role in
the development of ESC resistance in Salmonella. Resis-
tance to ESCs in Salmonella isolates is mainly due to the
production of acquired AmpC b-lactamases (including
blaDHA and blaCMY) and extended-spectrum b-lactamases
(ESBLs, including blaTEM, blaSHV and blaCTX-M).
6,7
Quinolone resistance in Enterobacteriaceae is mainly
due to point mutations in the quinolone resistance-
determining regions (QRDRs) of the target genes that
encode topoisomerases, namely DNA gyrase (gyrA and gyrB)
and DNA topoisomerase IV (parC and parE ).8,9 Down-
expression of porins or over-production of efflux pumps
also contribute to quinolone resistance by leading to
decreased membrane permeability, thus causing a reduc-
tion in the concentration of antimicrobial agents in the
cytoplasm.8,10 The major efflux pump systems identified in
Salmonella are resistanceenodulationedivision (RND)
efflux transporters (AcrAB-TolC and AcrEF) and EmrAB
(belongs to the major facilitator superfamily, MFS).1012
Quinolone resistance in Salmonella can also be mediated
by transferable plasmids containing several determinants,
including Qnr (topoisomerase protection), Aac(60)-Ib-cr
protein (quinolone and aminoglycoside acetylation), and
QepA and OqxAB (quinolone efflux pumps).8,13,14 In the
current study, cephalosporin- or quinolone-nonsusceptibleo C-Y, et al., Molecular character
qnrD or oqxAB in Taiwan, Jou
4Salmonella isolates collected from 1999 to 2008 in south-
ern Taiwan were characterized.
Materials and methods
Sampling and isolation of Salmonella
Over a period of 10 years between 1999 and 2008, 1416
Salmonella isolates were collected from inpatients hospi-
talized at the National Cheng Kung University Hospital,
Tainan, Taiwan. Seventy-six isolates showing quinolone
[ciprofloxacin (CIP) or levofloxacin (LVX)] or cephalosporin
[cefoxitin (FOX), ceftazidime (CAZ), ceftriaxone (CRO),
cefotaxime (CTX), or cefepime (FEP)] nonsusceptibility
were determined by agar dilution and selected for further
analysis. Among them, four pairs of isolates (01e1534 and
01e1548; 02e459e1 and 02e459e2; 04e955e1 and
04e955e2; 06e725, 06e731 and 06e801), containing more
than one Salmonella enterica serovar, were identified and
collected from a single patient at the same time.
Salmonella isolates were identified by colony
morphology, Gram stain, biochemical tests, and the Vitek 2
system (bioMe´rieux, Marcy l’Etoile, France) according to
the manufacturer’s recommendations. For serotyping, all
isolates were confirmed according to the Kaufmann-White
scheme and the serotyping protocols developed by the
Centers for Disease Control and Prevention, Atlanta, Ga.15
The isolates were stored at 80C in Brain Heart Infusion
(BHI) broth containing 30% glycerol (v/v) until used.
Antimicrobial susceptibility testing
Antimicrobial susceptibilities were determined by the disk
diffusion method on Mueller-Hinton (MH) agar according to
the Clinical and Laboratory Standards Institute (CLSI)
guidelines.16 ESBL-producing isolates were screened by the
double-disk synergy test in accordance with CLSI guide-
lines.17 All isolates were tested for minimum inhibitory
concentrations (MICs) of second-generation cephalosporin:
FOX (USP Standards, Rockville, MD); third-generation
cephalosporins: CTX (Sigma-Aldrich, St. Louis, MO), CAZ
(Sigma), CRO (Sigma); fourth-generation cephalosporin:
FEP (Sigma); quinolones: CIP (Sigma), and LVX (Sigma) by
the agar dilution method in accordance with CLSIization of antimicrobial susceptibility of Salmonella isolates: First
rnal of Microbiology, Immunology and Infection (2015), http://
Table 1 Oligonucleotide primers used in this study.
Primer Sequence (50e30) Reference
b-lactamase screening and sequencing
CTX-M-M13U GGTTAAAAAATCACTGCGTC 33
CTX-M-M13L TTGGTGACGATTTTAGCCGC
CTX-M-M9U ATGGTGACAAAGAGAGTGCA 33
CTX-M-M9L CCCTTCGGCGATGATTCTC
TEM-2A(F) CCCCTATTTGTTTATTTTTCT 34
TEM-1B(R) GACAGTTACCAATGCTTAAT
SHV-3A(F) CCGGGTTATTCTTATTTGTC 35
SHV-2B(R) TAGCGTTGCCAGTGCTCGAT
AmpC-1 ATGCAACAACGACAATCCATC 36
AmpC-2 GTTGGGGTAGTTGCGATTGG
DHA-1A CTGATGAAAAAATCGTTATC 37
DHA-1B ATTCCAGTGCACTCAAAATA
Gyrase sequencing (QRDR)
Sal-gyrA-F CGTTGGTGACGTAATCGG 38
Sal-gyrA-R CCGTACCGTCATAGTTAT
Sal-gyrB-F GCGCTGTCCGAACTGTACCT 39
Sal-gyrB-R CGGTGATCAGCGTCGCCACTTCC
PMQR screening and sequencing
qnrA-1A TTCAGCAAGAGGATTTCTCA 28
qnrA-1B GGCAGCACTATTACTCCCAA
qnrB-CS-1A GTTGGCGAAAAAATTGACAGAA 25
qnrB-CS-1B TTTGCAAGGCGTCAAACTGG
qnrB-CS-2A GTTGGCGAAAAAATTGACAGAA 25
qnrB-CS-2B TTTGCAAGGCGTCAAACTGG
qnrB-CS-3B ACTCCGAATTGGTCAGATCG
qnrS-1A CAATCATACATATCGGCACC 25
qnrS-1B TCAGGATAAACAACAATACCC
qnrD-FW CGAGATCAATTTACGGGGAATA 30
qnrD-Rev AACAAGCTGAAGCGCCTG
PMQR screening and sequencing
qnrD-FL-Fw ATGGAAAAGCACTTTATCA This study
qnrD-FL- Rev TTATCGGTGAACAATAAC
aac-Ib-F TTGCGATGCTCTATGAGTGGCTA 40
aac-Ib-R CTCGAATGCCTGGCGTGTTT
qepA-F CGTGTTGCTGGAGTTCTTC 41
qepA-R CTGCAGGTACTGCGTCATG
oqxA-F CTCGGCGCGATGATGCT 42
oqxA-R CCACTCTTCACGGGAGACGA
oqxB-S TTCTCCCCCGGCGGGAAGTAC 42
oqxB-A2 CTCGGCCATTTTGGCGCGTA
PMQR Z plasmid-mediated quinolone resistance;
QRDR Z quinolone resistance-determining region.
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quality control strain. Antibiotic susceptibility was inter-
preted according to CLSI guidelines.17
Pulsed-field gel electrophoresis (PFGE)
Isolates were subjected to PFGE analysis using the stan-
dardized PulseNet PFGE protocol for the subtyping of Sal-
monella.3,18 PFGE images were digitally recorded in tiff file
format using a Kodak EDAS290 System (Eastman Kodak Co,
Rochester, NY, USA).
Molecular characterization of antibiotic resistance
genes
Primers used in this study are described in Table 1. Forty-
four strains showing a decrease in susceptibility to cepha-
losporins were further studied by polymerase chain reac-
tion (PCR) amplification and sequencing of b-lactamase
genes. DNA was extracted by the boiling method, and the b-
lactamase-encoding genes were identified using specific
primers for the blaTEM, blaSHV, blaCMY, blaDHA, and blaCTX-M
genes, followed by DNA sequencing. The DNA sequences
and deduced amino acid sequences were compared with
genes in the GenBank database (http://www.ncbi.nlm.nih.
gov/genbank/) or the b-lactamase classification system
(http://www.lahey.org/studies/) to confirm the subtypes
of b-lactamase genes.
Sixty-two isolates showing nonsusceptibility to quino-
lones were screened for the presence of qnrA, qnrB, qnrD,
qnrS, aac(60)-Ib-cr, qepA, oqxA, and oqxB by specific PCR
amplification and sequencing. Among them, 36 isolates
showing high resistance to quinolone (MIC  32 mg/mL to
CIP or LVX) were further tested for amino acid changes in
the QRDR of GyrA and GyrB by PCR and sequencing.
Detection of efflux pump activity
To investigate the role of efflux pumps in quinolone-
nonsusceptible Salmonella isolates, MICs of CIP or LVX in
the presence or absence of efflux pump inhibitors Phe-Arg
b-naphthylamide dihydrochloride (PAbN) (Sigma) or
carbonyl-cyanide-m-chlorophenylhydrazone (CCCP)
(Sigma) were determined. In brief, PAbN at 20 mg/mL or
12.5 mM CCCP were incorporated in Mueller-Hinton agar,
and CIP or LVX susceptibility testing was performed in
parallel on agar plates with and without an efflux pump
inhibitor. Only when a reduction of more than 4-fold in MICs
following the addition of inhibitors was detected were the
isolates considered as a high efflux pump expression
strain.19,20
Southern blotting
Mini Qiagen columns and a plasmid extraction kit (Qiagen,
Valencia, CA) were used for plasmid DNA extraction.
Plasmid DNAs were digested by the restriction enzymes
XbaI or EcoRV. The DNA fragments of the oqxA and qnrD
(amplified by primers listed in Table 1) were labeled with
alkaline phosphatase as the probe (Amersham AlkPhos
Direct Labeling and detection system, AmershamPlease cite this article in press as: Kao C-Y, et al., Molecular character
identification of a plasmid carrying qnrD or oqxAB in Taiwan, Jou
dx.doi.org/10.1016/j.jmii.2015.03.004Biosciences, Piscataway, NJ). After hybridization, the
membranes were washed by primary wash buffer (2M urea,
0.1% SDS, 50mM sodium phosphate pH 7.0, 150mM NaCl,
1mM MgCl2, and 0.2% blocking reagent) and secondary wash
buffer (1M tris base, 2M NaCl, and 2mM MgCl2) at 55 C and
room temperature, respectively. The signals were detected
using a LAS3000 Intelligent Dark Box (Fujifilm, Japan).
Plasmid transformation
Plasmid DNA was extracted and used to transform E. coli
DH5a cells and Salmonella ATCC14028 cells by electropo-
ration (E. coli, 1.5 kV, 125 U, and 50 mF; Salmonella, 1.8 kV,ization of antimicrobial susceptibility of Salmonella isolates: First
rnal of Microbiology, Immunology and Infection (2015), http://
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Electrocell Manipulator ECM630 manual (BTX, Harvard
Apparatus, Inc., MA). The cells were plated on MH agar
plates containing CIP (0.064 mg/mL). The transformants
were then collected, and their plasmid and antimicrobial
susceptibility profiles were examined.
Conjugation experiments
The liquid mating-out assay was carried out to transfer
antibiotic determinants from quinolone-nonsusceptible
isolates 99e1020 to streptomycin-resistant E. coli C600 as
described previously.21 Transconjugants were selected on
LB plates containing streptomycin (256 mg/mL) (Sigma) and
CIP (0.064 mg/mL). The transconjugants were then
collected, and their plasmid and antimicrobial susceptibil-
ity profiles were examined.
Results
The prevalence of the cephalosporins- and
quinolones-nonsusceptible isolates
A total of 1416 Salmonella isolates were collected from a
hospital in southern Taiwan between 1999 and 2008 to
monitor the prevalence of cephalosporin- and quinolone-
nonsusceptible Salmonella. The trend in the prevalence
of FOX-, third-generation cephalosporin-, fourth-
generation cephalosporin- and quinolone-nonsusceptible
Salmonella isolates was generally stable and low with an
average of 3.1%, 2.3%, 0.3%, and 4.4%, respectively, during
10-year surveillance. Seventy-six isolates showing non-
susceptibility to either cephalosporins or quinolones were
selected for further analysis.Table 2 Serotypes and MIC ranges among 76 Salmonella isolate
Serotype,
N (%)
Choleraesuis
30 (39.5)
Typhimurium
19 (25.0)
Schw
9 (11
Antibiotic, MIC range (mg/ml), (n)b
FOX 4e256 (12) 4e >256 (11) 8
CTX 0.25e256 (8) 0.06e128 (11) 0.2
CAZ 0.5e256 (8) 0.25e256 (9) 0.2
CRO 0.12e256 (8) 0.06e256 (10) 0.1
FEP 0.12e32 (2) 0.06e16 (1) 0.12
CIP 1e128 (30) 0.015e8 (13) 2e
LVX 2e32 (30) 4e8 (14) 2
Nonsusceptible to
quinolone and
3rd generation
cephalosporin, n (%)
8 (26.7) 6 (31.6)
Nonsusceptible to
quinolone and
4th generation
cephalosporin, n (%)
2 (6.7) 1 (5.3)
CAZ Z ceftazidime; CIP Z ciprofloxacin; CRO Z ceftriaxone;
LVX Z levofloxacin.
a Eleven isolates belong to other serotypes including Paratyphi B (tw
isolates), Reading (one isolate), Braenderup (one isolate) and Bareill
b n stands for the number of nonsusceptible isolates among each se
Please cite this article in press as: Kao C-Y, et al., Molecular character
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dx.doi.org/10.1016/j.jmii.2015.03.004Among the 76 isolates, the numbers of nonsusceptible
isolates to FOX, CAZ, CTX, CRO, FEP, CIP, and LVX were 44
(57.9%), 33 (43.4%), 31 (40.8%), 32 (42.1%), 4 (5.3%), 61
(80.3%), and 62 (81.6%), respectively (Table 2). Moreover,
19 isolates (19/76, 25.0%) were nonsusceptible to quino-
lones and third-generation cephalosporin, including eight S.
enterica Choleraesuis isolates, six S. Typhimurium isolates,
two S. Albany isolates, one S. Stanley isolate, one S. Brunei
isolate, and one S. Braenderup isolate. Four isolates (4/76,
5.3%) were nonsusceptible to quinolones and fourth-
generation cephalosporin, including two S. Choleraesuis
isolates, one S. Typhimurium isolate, and one S. Albany
isolate (Table 2).
Comparison of serovars and PFGE genotypes
Among the 76 isolates, S. Choleraesuis (30/76, 39.5%), S.
Typhimurium (19/76, 25.0%), S. Schwarzengrund (9/76,
11.8%), and S. Enteritidis (7/76, 9.2%) were the four most
common serovars (Table 2). In addition, the PFGE results
revealed that 18 S. Choleraesuis isolates (18/30, 60.0%)
belonged to the SCX.001 pattern and 6 S. Enteritidis isolates
(6/7, 85.7%) belonged to the SEX.001 pattern, the patterns
being from a previous study (Figure 1).22 No dominant PFGE
pattern of S. Typhimurium or S. Schwarzengrund isolates
were identified (Figure 1).
Molecular analysis of b-lactamase genes
Forty-four cephalosporin-nonsusceptible isolates were
subjected to screening of the b-lactamase genes. The
nucleotide sequence analysis of the TEM, CMY, and CTX-M
genes are shown in Table 3. Among them, three isolates
(6.8%) contained only TEM-1 and four isolates (9.1%)s.
arzengrund
.8)
Enteritidis
7 (9.2)
Othersa
11 (14.5)
Total
76 (100)
e64 (6) 8e >256 (6) 4e >256 (9) 4e >256 (44)
5e1 (0) 0.25e32 (6) 0.25e128 (8) 0.06e128 (33)
5e1 (0) 0.5e128 (6) 0.5e256 (8) 0.25e256 (31)
2e1 (0) 0.06e64 (6) 0.06e256 (8) 0.06e256 (32)
e0.5 (0) 0.5e1 (0) 0.12e32 (1) 0.06e32 (4)
256 (9) 0.03e32 (1) 0.015e8 (8) 0.015e256 (61)
e64 (9) 0.06e16 (1) 0.06e4 (8) 0.06e64 (62)
0 (0) 0 (0) 5 (45.5) 19 (25.0)
0 (0) 0 (0) 1 (9.1) 4 (5.3)
CTX Z cefotaxime; FEP Z cefepime; FOX Z cefoxitin;
o isolates), Stanley (isolates), Albany (two isolates), Brunei (two
y (one isolate).
rotype.
ization of antimicrobial susceptibility of Salmonella isolates: First
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Figure 1. Serotypes and pulsed-field gel electrophoresis (PFGE) patterns of 76 Salmonella isolates. Eleven serotypes were
identified by PFGE among the 76 Salmonella isolates. The dendrogram was generated with a band position tolerance of 0.8%.
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Table 3 Serotypes and b-lactamase genes among 44 cephalosporin nonsusceptible Salmonella isolates.
Serotype
N (%)
Choleraesuis
12 (27.3)
Typhimurium
11 (25.0)
Schwarzengrund
6 (13.6)
Enteritidis
6 (13.6)
Othersa
9 (20.5)
Total
44 (100)
b-lactamase, N (%)a
TEM-1 0 (0) 2 (18.2) 0 (0) 0 (0) 1 (11.1) 3 (6.8)
CMY-2 0 (0) 2 (18.2) 0 (0) 0 (0) 2 (22.2) 4 (9.1)
TEM-1/CMY-2 7 (58.3) 6 (54.5) 1 (16.7) 6 (100) 5 (55.6) 25 (56.8)
TEM-1/CMY-14 1 (8.3) 0 (0) 0 (0) 0 (0) 0 (0) 1 (2.3)
TEM-1/CMY-2/CTX-M-3 0 (0) 0 (0) 0 (0) 0 (0) 1 (11.1) 1 (2.3)
TEM-1/CMY-2/CTX-M-15 1 (8.3) 0 (0) 0 (0) 0 (0) 0 (0) 1 (2.3)
a Isolates showing nonsusceptibility to at least one select cephalosporin were analyzed for the presence of b-lactamase genes. No
blaSHV- or blaDHA-producers were found. No select b-lactamase genes were detected in nine isolates showing nonsusceptibility to
cephalosporin.
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identified in 25 and one TEM-1-containing isolates,
respectively (Table 3). Moreover, two isolates (01e799 and
03e1167) harboring CTX-M-type genes also contained TEM-1
and CMY-2 (Table 3). No SHV- or DHA-producers were found.Characterization of plasmid-mediated quinolone
resistance
In order to determine the prevalence and characteristics of
plasmid-mediated quinolone resistance (PMQR) in Salmo-
nella in Taiwan, Qnr peptides (qnrA, qnrB, qnrS, and qnrD),
aminoglycoside acetyl-transferase (aac(60)-Ib-cr) and efflux
pump associated determinants (qepA, oqxA, and oqxB)
were determined by PCR in 62 quinolone-nonsusceptible
isolates. Among 26 isolates showing low resistance to qui-
nolone (MIC < 32 mg/mL), qnrS, qnrD, and oqxAB were
found in three (06e728, 07e68, 08e108), one (06e667) and
nine (99e997, 99e1020, 00e387, 01e235, 02e345, 02e899,
02e994, 04e1160, 06e417) isolates, respectively (Table 4).
In addition, one isolate (06e688) harboring the qnrD gene
also contained aac(60)-Ib-cr (Table 4). Among 36 isolatesTable 4 Quinolone resistance mechanism and MIC ranges amon
Isolatea Low resistance (n Z
MIC range (mg/mL) LVX (n) C
Mechanism
oqxAB 1e4 (9) 2
qnrD 1 (1) 0
qnrS 1e8 (3) 1
qnrDþaac(60)-Ib-cr 1 (1) 0
GyrA (S83F/D87N) ND N
GyrA (S83F/D87G) ND N
GyrA (S83F/D87N)þefflux ND N
GyrA (S83F/D87N)þoqxAB ND N
GyrA (S83F/D87G)þefflux ND N
Total (n) 14 1
CIP Z ciprofloxacin; LVX Z levofloxacin; MIC Z minimum inhibitory
a Isolates showing quinolone-nonsusceptibility were divided into low
ciprofloxacin or levofloxacin). Thirty-six isolates showing high resistan
and the over-expression of efflux pump. No GyrB mutations were ide
Please cite this article in press as: Kao C-Y, et al., Molecular character
identification of a plasmid carrying qnrD or oqxAB in Taiwan, Jou
dx.doi.org/10.1016/j.jmii.2015.03.004showing high resistance to quinolone, oqxAB was found in
only one isolate (01e889) (Table 4). Moreover, qnrS was
only found in S. Typhimurium isolates and qnrD was found in
S. Bareilly and S. Stanley isolates. However, no qnrA, qnrB,
and qepA genes were identified.
The southern blotting hybridization showed that iden-
tical digestion patterns of a w10.2 kB qnrS-plasmid were
observed in all three isolates (data not shown). In addition,
a w4.2 kB plasmid containing the qnrD determinant was
extracted from isolates 06e667 and 06e688 and confirmed
by southern blotting (Figure 2A).
In order to clarify the effect of the qnrD-containing
plasmid, a conjugation assay was used to transfer qnrD-
plasmid into E. coli C600 cells. However, no transconjugant
was obtained in the current experimental condition. As a
result, plasmids from strain 06e688 were extracted and
electroporated into E. coli DH5a cells, and the plasmid and
antimicrobial susceptibility profiles of the transformant
were examined (Table 5). The results showed that the MIC
of CIP and LVX were increased 12-fold (0.016 to 0.19 mg/mL)
and 6-fold (0.032 to 0.19 mg/mL) in the transformant,
respectively, compared to the DH5a cells (Table 5). How-
ever, the sensitivities of cephalosporins were identicalg 62 Salmonella isolates.
26) High resistance (n Z 36)
IP (n) LVX (n) CIP (n)
e4 (9) 0 0
.5 (1) 0 0
e4 (3) 0 0
.5 (1) 0 0
D 32e128 (24) 16e32 (24)
D 64e128 (2) 32 (2)
D 32e256 (4) 32 (4)
D 64 (1) 16 (1)
D 128e256 (4) 32e64 (4)
4 35 35
concentration; ND Z not detected.
resistance group and high resistance group (MIC  32 mg/mL to
ce to quinolones were analyzed for the QRDR of GyrA and GyrB,
ntified.
ization of antimicrobial susceptibility of Salmonella isolates: First
rnal of Microbiology, Immunology and Infection (2015), http://
Figure 2. Detection of qnrD- and oxqAB-containing plasmids in clinical isolates. (A) Southern blotting analysis of qnrD-containing
plasmid. The qnrD-containing plasmids were extracted from clinical isolates (06e667 and 06e688) and digested with restriction
enzyme (XbaI or EcoRV). Southern blotting was performed with the probe of qnrD; (B) Southern blotting analysis of oqxAB-con-
taining plasmid. The oqxAB-containing plasmids were extracted from nine clinical isolates (99e997, 99e1020, 00e387, 01e235,
02e345, 02e899, 02e994, 04e1160, and 06e417) and digested with restriction enzyme XbaI. Southern blotting was performed with
the probe of oqxA. M1 Z l/HindIII marker; M2 Z GeneRuler DNA ladder marker; U Z plasmid without enzyme digestion.
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diffusion (Table 5). Moreover, aac(60)-Ib-cr was not detec-
ted in the transformant, as determined by PCR. As a result,
qnrD and aac(60)-Ib-cr are located in two different
plasmids.Table 5 MIC of various antimicrobials for qnr- or oqxAB positive
Strain PMQR MICs (mg/mL) (fold inc
CIP LVX
qnrD
06e688 qnrD, aac(60)-Ib-cr 0.75 0.25
DH5a d 0.016 0.032
Transformant qnrD 0.19 (12) 0.19
oqxAB
99e1020 oqxA, oqxB 0.38 0.75
E. coli C600 0.016 0.023
Transconjugant oqxA, oqxB 0.25 (16) 0.5 (2
ATCC 14028 0.008 0.032
Transformant oqxA, oqxB 0.064 (8) 0.094
CAZ Z ceftazidime; CIP Z ciprofloxacin; CRO Z ceftriaxone;
LVX Z levofloxacin; MIC Z minimum inhibitory concentration; NA Z
a The MIC for quinolones was measured by E test strips.
b The susceptibility variations for cephalosporins and nalidixic acid
Please cite this article in press as: Kao C-Y, et al., Molecular character
identification of a plasmid carrying qnrD or oqxAB in Taiwan, Jou
dx.doi.org/10.1016/j.jmii.2015.03.004Although no specific oqxAB-containing plasmid was
found to be spread in Taiwan as determined by southern
blotting, identical digestion patterns of an w18 kB oqxAB-
plasmid were observed in three isolates (99e997, 99e1020,
and 01e235) (Figure 2B). In order to clarify the effect of theSalmonella isolates and their transconjugant or transformant.
reased)a Zone size of disk diffusion (mm)b
FOX CAZ CTX FEP CRO NA
24 35 29 33 ND ND
29 38 36 40 ND ND
(6) 28 40 37 40 ND ND
24 25 24 21 26 7
31 32 34 34 33 21
2) 28 27 26 23 28 7
25 28 30 31 29 22
(3) 24 27 30 32 30 13
CTX Z cefotaxime; FEP Z cefepime; FOX Z cefoxitin;
nalidixic acid; ND Z not detected.
were measured by disk diffusion methods.
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+ MODELoqxAB-plasmid, plasmid from strain 99e1020 was extracted
and electroporated into Salmonella ATCC14028 cells. In
addition, the plasmid of strain 99e1020 was further
analyzed by conjugation into E. coli C600 cells (Table 5).
The results showed that the MIC of CIP and LVX were
increased 8-fold (0.008 to 0.064 mg/mL) and 3-fold (0.032 to
0.094 mg/mL) in the transformant, respectively, compared
to the Salmonella ATCC14028 (Table 5). The decrease of
the inhibitory zone of nalidixic acid was also observed in
the transformant, compared to the Salmonella ATCC14028
(22 mm to 13 mm) (Table 5). For the transconjugant, 16-
fold (0.016 to 0.25 mg/mL) and 22-fold (0.023 to 0.5 mg/
mL) increases of MIC of CIP and LVX, and a decrease of the
inhibitory zone of nalidixic acid (21 mm to 7 mm),
compared to the C600 cells, were observed (Table 5).
Importantly, the transconjugant showed a slight decrease
of sensitivities to cephalosporins, and this phenotype
change was not observed in the oqxAB-transformant Sal-
monella ATCC14028 cells (Table 5).
Efflux pump activity and QRDR mutations
Thirty-six isolates showing high resistance to CIP or LVX
(MIC  32 mg/mL) were the subjects of experiments to
determine the activity of efflux pumps and analyze the
QRDR of GyrA and GyrB (Table 4). Two well-known efflux
pump inhibitors, PAbN and CCCP, inhibit different efflux
pumps and were used to determine the activity of efflux
pumps in quinolone-resistant isolates. The results showed
that a greater than or equal to, 4-fold concentration
decrease in MIC for quinolones, as tested in combination
with either efflux pump inhibitor, PAbN or CCCP, was shown
in eight (22.2%) and none of the 36 isolates, respectively.
The sequencing results of QRDR of GyrA and GyrB among
36 quinolone highly resistant isolates showed 29 (80.6%) and
6 (16.7%) isolates contained S83F/D87N and S83F/D87G
amino acid substitutions in the QRDR of GyrA, respectively.
Only one isolate, 05e549, showed high resistance to CIP
and LVX without GyrA substitutions. Moreover, no changes
were found in GyrB.
Discussion
In the present study, it was demonstrated that the average
prevalence of FOX-, third-generation cephalosporin-,
fourth-generation cephalosporin-, and quinolone- non-
susceptible Salmonella isolates was 3.1%, 2.3%, 0.3%, and
4.4%, respectively, during the longitudinal surveillance of a
10-year study in Taiwan. Mutations of QRDR in GyrA were
the major cause of high resistance to quinolones. In addi-
tion, the qnrD- and oqxAB-plasmids, which contribute to
the decrease of quinolone-sensitivity in Salmonella in
Taiwan were first identified and characterized.
Among 76 isolates showing nonsusceptibility to either
cephalosporins or quinolones, S. enterica Choleraesuis
(39.5%), S. Typhimurium (25.0%), S. Schwarzengrund
(11.8%), and S. Enteritidis (9.2%), were the four most
common serovars (Table 2). Kuo et al.3 showed that S.
Enteritidis, S. Typhimurium, S. Stanley, S. Newport, and S.
Albany were the five most common serovars isolated in
Taiwan from 2004 to 2012, and they accounted for 70% ofPlease cite this article in press as: Kao C-Y, et al., Molecular character
identification of a plasmid carrying qnrD or oqxAB in Taiwan, Jou
dx.doi.org/10.1016/j.jmii.2015.03.004the entire collection. These results indicated that although
S. Choleraesuis, S. Schwarzengrund, and S. Typhimurium
were not the most dominant serovars in Taiwan, they dis-
played the highest resistance profiles, in particular, all
Choleraesuis isolates were quinolone-nonsusceptible (Table
2), these results were in agreement with previous
studies.3,23 In addition, 28 Choleraesuis isolates (28/30,
93.3%) in this study were isolated from the blood of pa-
tients. The results raised the possibility of not only high
antimicrobial resistance but also the high virulence poten-
tial of S. Choleraesuis isolates. Moreover, highly similar
PFGE patterns of S. Choleraesuis isolates were identified,
indicating that the specific SCX.001 clone was widespread
in Taiwan (Figure 1).
Although the presence of blaCMY-2 in Salmonella leads to
ESC resistance,24,25 only two isolates were defined as ESBL-
Salmonella in the current study collection. However, all 31
CMY-2 producers showed resistance to ESCs except FEP.
CTX-M-3-like and CTX-M-15-like genes were present and
responsible for the ESBL-phenotype. Moreover, two isolates
harboring the CTX-M-type gene also contained TEM-1 and
CMY-2 (Table 3). Although the prevalence of ESBL-Salmo-
nella and CTX-M-type genes in Taiwan is still low, it is
important and worth monitoring continually. In addition,
none of select b-lactamase genes were detected in nine
isolates (9/44, 20.5%) showing nonsusceptibility to cepha-
losporin. As a result, whether other b-lactamases, including
blaAAC, blaPSE, or blaOXA participate in decreasing suscep-
tibility to cephalosporin in these Salmonella isolates
remained to be determined.26,27
A greater than or equal to fourfold concentration
decrease in MIC for quinolones, as tested in combination
with either efflux pump inhibitor, PAbN or CCCP, was shown
in eight (22.2%) and none of the 36 isolates, respectively
(Table 4). This indicates that an active PAbN-sensitive
efflux pump contributes to the decrease in quinolone sus-
ceptibility of Salmonella isolates. The major PAbN-sensitive
efflux system identified in Salmonella quinolone resistance
is AcrAB-TolC.1012 As a result, the expression of efflux
pump genes AcrAB-TolC was further determined, and the
results showed no over-expression of acrB in these eight
isolates (data not shown). However, whether other efflux
systems such as EmrAB, which belongs to the major facili-
tator superfamily, and AcrEF, an RND member, increase
expression levels in quinolone-resistant isolates remained
to be determined.
Qnr genes for quinolone resistance have been found on
plasmids varying in size and incompatibility specificity,
indicating that the spread of multiple plasmids has been
responsible for the dissemination of this resistance among
Enterobacteriaceae around the world. Although the
occurrence of qnrB2 and qnrS1 in Salmonella isolates,25 and
qnrA, qnrB, and qnrS among clinical isolates of Enter-
obacter cloacae were identified in Taiwan previously,28 this
is the first report to demonstrate the PMQR determinants
qnrD and oqxAB in Salmonella in Taiwan.
qnrS was identified on an w10.2 kB plasmid with similar
restriction enzyme digestion patterns to previously re-
ported findings (plasmid NC010993.1),25 which exhibited >
99% nucleotide sequence identity with plasmid TPqnrS-1a
from a S. Typhimurium DT193 strain reported from
the UK.29ization of antimicrobial susceptibility of Salmonella isolates: First
rnal of Microbiology, Immunology and Infection (2015), http://
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similar to one from a previous study,30 and contributed to
decreased quinolone susceptibility (Table 5). As a result, it
is worth monitoring the spread of the qnrD plasmid among
Salmonella in Taiwan. No specific oqxAB-plasmid was
identified in this study (Figure 2B). It was found that oqxAB-
plasmids varied in size and incompatibility specificity,
indicating that multiple oqxAB-plasmids have been
disseminated. Interestingly, an E. coli transconjugant with
the oqxAB-plasmid showed decreased susceptibility to
cephalosporins, but this phenotype change was not
observed in the Salmonella transformant harboring the
same plasmid (Table 5). The mechanism leading to this
different phenotype is worth studying. In addition, the MIC
of CIP and LVX was higher in isolate 99e1020 compared to
the Salmonella transformant, raising the possibility that
other mechanisms participated in the decreased sensitivity
to quinolones in 99e1020 (Table 5).
Although the transformant and conjugant with PMQR
determinants (qnrD or oqxAB) showed decreased suscepti-
bility to quinolones, the MIC level of quinolones was still
low (Table 5). In addition, all 36 isolates but one (05e549)
showing high resistance to quinolones (MIC  32 mg/mL) had
GyrA mutations (Table 4). Whether isolate 05e549 contains
ParC and ParE mutations is worth clarifying.
Rushdy et al.31 showed that five Salmonella isolates
totally resistant to all quinolones had alterations in outer
membrane proteins, including disappearance of some or all
of these proteins: Omp-A, Omp-C, Omp-D, and Omp-F. The
role of Omp loss in quinolone resistance was clarified in E.
coli,32 but is still unclear in Salmonella. As a result,
whether the down-expression of Omps contributes to qui-
nolone resistant Salmonella in Taiwan is worth
investigating.
In conclusion, numbers of cephalosporin- and quinolone-
nonsusceptible Salmonella remained stable and of low
prevalence in Taiwan from 1999 to 2008. Mutations of GyrA
are the major cause of high-level quinolone resistance.
Plasmid-mediated quinolone resistance, including qnrD,
qnrS, and oqxAB, are also involved in quinolone-
nonsusceptible Salmonella. Importantly, this is the first
study to identify and characterize qnrD and oqxAB plasmids
in Salmonella in Taiwan.
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